Alteration of drug biotransformation and elimination during infection and inflammation

Abdel-Razzak, 1994, Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture, Mol Pharmacol, 46, 1100 Abdel-Razzak, 1995, Interleukin-1 beta antagonizes phenobarbital induction of several major cytochromes P450 in adult rat hepatocytes in primary culture, FEBS Lett, 366, 159, 10.1016/0014-5793(95)00513-9 Akinyinka, 2000, The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians, Eur J Clin Pharmacol, 56, 159, 10.1007/s002280050735 Anandatheerthavarada, 1993, The chronic administration of nicotine induces cytochrome P450 in rat brain, J Neurochem, 60, 1941, 10.1111/j.1471-4159.1993.tb13424.x Anari, 1993, Modulatory effect of hyperthermia on hepatic microsomal cytochrome P450 in mice, Biochem Pharmacol, 46, 307, 10.1016/0006-2952(93)90419-W Anari, 1995, The duration of induction and species influences the downregulation of cytochrome P450 by the interferon inducer polyinosinic acid-polycytidylic acid, Drug Metab Dispos, 23, 536 Anolik, 1982, Transient alteration of theophylline half-life: possible association with Herpes simplex infection, Ann Allergy, 49, 109 Ansher, 1993, Pertussis toxin-induced alterations of murine hepatic drug metabolism following administration of diphtheria and tetanus toxoids and pertussis vaccine adsorbed, Infect Immun, 61, 4240, 10.1128/IAI.61.10.4240-4247.1993 Ansher, 1994, Alterations of hepatic drug metabolism in mice following infection with murine retrovirus LP-BM5, Immunopharmacology, 27, 215, 10.1016/0162-3109(94)90018-3 Armstrong, 1993, Hepatic cytochrome P450 and related drug biotransformation during an outbreak of mouse hepatitis virus in a colony of Swiss BALB/c mice, Can J Physiol Pharmacol, 71, 188, 10.1139/y93-027 Armstrong, 1993, Mechanism of hepatic cytochrome P450 modulation during Listeria monocytogenes in mice, Mol Pharmacol, 43, 542 Armstrong, 1994, Factors involved in the down-regulation of cytochrome P450 during Listeria monocytogenes infection, Int J Immunopharmacol, 16, 747, 10.1016/0192-0561(94)90094-9 Arvin, 1995, Brain injury and inflammation, a putative role for TNF-alpha, Ann N Y Acad Sci, 116, 62, 10.1111/j.1749-6632.1995.tb16561.x Azri, 1987, Depression of murine hepatic mixed function oxidase during infection with Listeria monocytogenes, J Pharmacol Exp Ther, 243, 1089 Azri, 1991, Factors involved in the depression of hepatic mixed function oxidase during infections with Listeria monocytogenes, Int J Immunopharmacol, 13, 197, 10.1016/0192-0561(91)90099-S Badawi, 1993, Possible mechanisms of alteration in the capacities of carcinogen metabolizing enzymes during schistosomiasis and their role in bladder cancer induction, J Int Med Res, 21, 281, 10.1177/030006059302100601 Baer, 1986, Altered distribution of debrisoquine oxidation phenotypes in patients with systemic lupus erythematosus, Arthritis Rheum, 29, 843, 10.1002/art.1780290705 Barakat, 1996, Effect of nifedipine on the elimination of theophylline in the rabbit subjected to hypoxia or to an inflammatory reaction, J Pharm Pharmacol, 48, 906, 10.1111/j.2042-7158.1996.tb05999.x Barclay, 1999, Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent, J Pharmacol Exp Ther, 290, 1250 Barker, 1992, Interleukin-1 beta suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes, J Biol Chem, 267, 8050, 10.1016/S0021-9258(18)42406-4 Barker, 1994, Down-regulation of P4501A1 and P4501A2 mRNA expression in isolated hepatocytes by oxidative stress, J Biol Chem, 269, 3985, 10.1016/S0021-9258(17)41731-5 Berg-Candolfi, 1996, Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection, Int J Parasitol, 26, 1321, 10.1016/S0020-7519(96)00111-7 Berg Candolfi, 1996, Suppression of intestinal and hepatic cytochrome P4503A in murine Toxoplasma infection. Effects of N-acetylcysteine and N(G)-monomethyl-L-arginine on the hepatic suppression, Xenobiotica, 26, 381, 10.3109/00498259609046717 Bergh, 1992, Reconstitution of the brain mixed function oxidase system: purification of NADPH-cytochrome P450 reductase and partial purification of cytochrome P450 from whole rat brain, J Neurochem, 59, 575, 10.1111/j.1471-4159.1992.tb09408.x Beurton, 1999, Transcriptional activation of CYP2C, MxA and Fas in sudden infant death syndrome, Int J Mol Med, 3, 33 Biro, 1994, Consequences of challenge infections with Fasciola hepatica on rat liver P450-dependent metabolism of sex hormones, J Steroid Biochem Mol Biol, 51, 209, 10.1016/0960-0760(94)90095-7 Bleau, 2000, Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine-induced inflammation: the role of cytokines, Br J Pharmacol, 130, 1777, 10.1038/sj.bjp.0703486 Brockmeyer, 1998, Changes of antipyrine pharmacokinetics during influenza and after administration of interferon-alpha and -beta, Int J Clin Pharmacol Ther, 36, 309 Calleja, 1997, Differential effects of interleukin-1beta, interleukin-2, and interferon-gamma on the inducible expression of CYP 1A1 and CYP 1A2 in cultured rabbit hepatocytes, Biochem Biophys Res Commun, 239, 273, 10.1006/bbrc.1997.7468 Calleja, 1998, Comparative effects of cytokines on constitutive and inducible expression of the gene encoding for the cytochrome P450 3A6 isoenzyme in cultured rabbit hepatocytes: consequences on progesterone 6beta- hydroxylation, Biochem Pharmacol, 56, 1279, 10.1016/S0006-2952(98)00178-6 Calleja, 2000, Comparison of hepatic and renal drug-metabolising enzyme activities in sheep given single or two-fold challenge infections with fasciola hepatica, Int J Parasitol, 30, 953, 10.1016/S0020-7519(00)00070-9 Carelli, 1996, Modulation of constitutive and inducible hepatic cytochrome(s) P-450 by interferon beta in mice, J Hepatol, 24, 230, 10.1016/S0168-8278(96)80034-1 Carlson, 1996, Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450, Mol Pharmacol, 49, 796 Catignani, 1989, Increased susceptibility to pentobarbital following mouse cytomegalovirus, J Biochem Toxicol, 4, 221, 10.1002/jbt.2570040404 Cavaillon, 1995, Cytokines in inflammation, C R Seances Soc Biol Fil, 189, 531 Cha, 1976, Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice, J Pharmacol Exp Ther, 199, 432 Chambras, 1999, Xenobiotic-metabolizing enzymes in carp (Cyprinus carpio) liver, spleen, and head kidney following experimental Listeria monocytogenes infection, J Toxicol Environ Health, 56, 205, 10.1080/009841099158150 Chang, 1978, Altered theophylline pharmacokinetics during acute respiratory viral illness, Lancet, i, 1132, 10.1016/S0140-6736(78)90305-7 Chen, 1995, Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6, Mol Pharmacol, 47, 940 Chen, 1992, Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat, Biochem Pharmacol, 44, 137, 10.1016/0006-2952(92)90047-M Chen, 1994, Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics, Clin Pharmacol Ther, 55, 649, 10.1038/clpt.1994.82 Chindavijak, 1987, In-vitro biotransformation of antipyrine, lignocaine and propranolol in the liver of rats with turpentine-induced inflammation, J Pharm Pharmacol, 39, 883, 10.1111/j.2042-7158.1987.tb03122.x Chomarat, 1997, Distinct time courses of increase in cytochromes P450 1A2, 2A5 and glutathione S-transferases during the progressive hepatitis associated with Helicobacter hepaticus, Carcinogenesis, 18, 2179, 10.1093/carcin/18.11.2179 Chow, 1998, The effect of chronic retrovirus infection and immune dysfunction on the P-450-mediated activation of acetaminophen in mouse liver microsomes, Biopharm Drug Dispos, 19, 9, 10.1002/(SICI)1099-081X(199801)19:1<9::AID-BDD70>3.0.CO;2-F Clark, 1995, Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes, Biochem Pharmacol, 49, 97, 10.1016/0006-2952(94)00438-R Clarke, 1979, Theophylline pharmacokinetics during respiratory viral infection, Lancet, i, 492, 10.1016/S0140-6736(79)90844-4 Corbett, 1973, Effect of PR-8 viral respiratory infection on benzo(a)pyrene hydroxylase activity in BALB/c mice, J Nat Cancer Inst, 50, 779, 10.1093/jnci/50.3.779 Craig, 1990, Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver, Mol Pharmacol, 38, 313 Craig, 1993, Interferon suppresses erythromycin metabolism in rats and human subjects, Hepatology, 17, 230, 10.1002/hep.1840170212 Cribb, 1993, Dissociation of xanthine oxidase induction and cytochrome P450 depression, Biochem Pharmacol, 46, 2114, 10.1016/0006-2952(93)90658-J Cribb, 1994, Regulation of cytochrome P-4501A and cytochrome P-4502E induction in the rat, J Pharmacol Exp Ther, 268, 487 Cui, 2001, Molecular cloning and regulation of expression of two novel mouse CYP4F genes: expression in peroxisome proliferator-activated receptor alpha-deficient mice upon lipopolysaccharide and clofibrate challenges, J Pharmacol Exp Ther, 296, 542 De Flora, 1989, Enhanced metabolic activation of chemical hepatocarcinogens in woodchucks infected with hepatitis B virus, Carcinogenesis, 10, 1099, 10.1093/carcin/10.6.1099 Delaporte, 1997, Cytochrome P4501A1 and cytochrome P4501A2 are downregulated at both transcriptional and post-transcriptional levels by conditions resulting in interferon-alpha/beta induction, Life Sci, 60, 787, 10.1016/S0024-3205(97)00006-4 Delaporte, 1993, Modulation of rat hepatic CYP3A1 induction by the interferon inducer polyinosinic acid-polycytidylic acid (polyic), Drug Metab Dispos, 21, 520 Delaporte, 1995, Interferon-mediated changes in the expression of CYP1A1 in human B lymphoblastoid (AHH-1 TK+/-) cells, Can J Physiol Pharmacol, 73, 1692, 10.1139/y95-732 Dinarello, 2000, Proinflammatory cytokines, Chest, 118, 503, 10.1378/chest.118.2.503 Donato, 1997, Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes, J Pharmacol Exp Ther, 281, 484 Eichizen, 1990, Effects of subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis, Clin Pharmacol, 30, 562, 10.1002/j.1552-4604.1990.tb03621.x Eiseman, 1982, Effect of honeybee (Apis mellifera) venom on the course of adjuvant-induced arthritis and depression of drug metabolism in the rat, Biochem Pharmacol, 31, 1139, 10.1016/0006-2952(82)90354-9 El-Bassiouni, 1984, Hepatic microsomal enzymes in S. mansoni infected mice: II. Effect of duration of infection and lindane administration on aminopyrine demethylase and aniline hydroxylase, J Environ Sci Health [B], 19, 193, 10.1080/03601238409372425 Elin, 1975, Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance, Clin Pharmacol Ther, 17, 447, 10.1002/cpt1975174447 El-Kadi, 1998, Depression of the hepatic cytochrome P450 by an acute inflammatory reaction: characterization of the nature of mediators in human and rabbit serum, and in the liver, Life Sci, 63, 1361, 10.1016/S0024-3205(98)00400-7 El-Kadi, 1997, Down-regulation of the hepatic cytochrome P450 by an acute inflammatory reaction: implication of mediators in human and animal serum and in the liver, Br J Pharmacol, 121, 1164, 10.1038/sj.bjp.0701232 El-Kadi, 2000, Role of reactive oxygen intermediates in the decrease of hepatic cytochrome P450 activity by serum of humans and rabbits with an acute inflammatory reaction, Drug Metab Dispos, 28, 1112 Endo, 1981, Hepatic drug-metabolizing enzyme activities and anti-inflammatory potency of hydrocortisone in rats with granulomatous inflammation, Res Commun Chem Pathol Pharmacol, 33, 195 Ferrari, 1993, Interleukin-1 beta differentially represses drug-metabolizing enzymes in arthritic female rats, J Pharmacol Exp Ther, 264, 1012 Fleetham, 1978, Theophylline pharmacokinteics and respiratory infections, Lancet, ii, 898, 10.1016/S0140-6736(78)91612-4 Floyd-Smith, 1981, Interferon action: RNA cleavage pattern of a (2′-5′)oligoadenylate–dependent endonuclease, Science, 212, 1030, 10.1126/science.6165080 Forsyth, 1982, The effect of fever on antipyrine metabolism in children, Br J Clin Pharmacol, 13, 811, 10.1111/j.1365-2125.1982.tb01871.x Fukuda, 1994, Suppression of cytochrome P450IA1 by interleukin-6 in human HepG2 hepatoma cells, Biochem Pharmacol, 47, 1187, 10.1016/0006-2952(94)90391-3 Fukuda, 1992, Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 1A1, 1A2 and III3A in human hepatoma cells, Biochem Biophys Res Commun, 184, 960, 10.1016/0006-291X(92)90684-D Galtier, 1983, Impairment of drug metabolism by the liver in experimental fascioliasis in the rat, J Pharm Pharmacol, 35, 729, 10.1111/j.2042-7158.1983.tb02879.x Galtier, 1994, Fasciola hepatica: liver microsomal membrane functions in host rat, Exp Parasitol, 78, 175, 10.1006/expr.1994.1017 Ghezzi, 1984, Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers, Biochem Biophys Res Commun, 119, 144, 10.1016/0006-291X(84)91630-9 Ghezzi, 1985, Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcysteine in mice, Cancer Res, 45, 3444 Ghezzi, 1986, Role of interleukin-1 in the depression of liver drug metabolism by endotoxin, Infect Immun, 54, 837, 10.1128/IAI.54.3.837-840.1986 Gonzalez, 1990, Evolution of the P450 gene superfamily: animal-plant ′warfare,′ molecular drive and human genetic differences in drug oxidation, Trends Genet, 6, 182, 10.1016/0168-9525(90)90174-5 Gooderham, 1986, Depression of cytochrome P-450 and alterations of protein metabolism in mice treated with the interferon inducer polyriboinosinic acid X polyribocytidylic acid, Arch Biochem Biophys, 250, 418, 10.1016/0003-9861(86)90744-7 Goulden, 1988, Changes in serum anticonvulsant levels with febrile illness in children with epilepsy, Can J Neurol Sci, 15, 281, 10.1017/S031716710002775X Greenwald, 1990, Viral induced changes in theophylline handling in children, Am J Asthma Allergy Pediatr, 3, 162 Hodgson, 1995, The role of nitric oxide generation in interferon-evoked cytochrome P450 down-regulation, Int J Immunopharmacol, 17, 995, 10.1016/0192-0561(95)00083-6 Iber, 1999, Modulation of drug metabolism in infectious and inflammatory diseases, Drug Metab Rev, 31, 29, 10.1081/DMR-100101906 Iber, 2000, Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NF-kappaB binding at the transcription start site, Arch Biochem Biophys, 377, 187, 10.1006/abbi.2000.1772 Ichijo, 1994, Central interleukin-1B enhances splenic sympathetic nerve activity in rats, Brain Res Bull, 34, 547, 10.1016/0361-9230(94)90139-2 Imaoka, 1990, Induction and regulation of cytochrome P450 K-5 (lauric acid hydroxylase) in rat renal microsomes by starvation, Biochim Biophys Acta, 1036, 18, 10.1016/0304-4165(90)90208-E Ishikawa, 1990, Modulation of zoxazolamine metabolism in carrageenan-induced inflammation in rats, Res Commun Chem Pathol Pharmacol, 70, 367 Ishizuki, 1983, Reduced drug metabolism in isolated hepatocytes from adjuvant arthritic rats, Res Commun Chem Pathol Pharmacol, 39, 261 Janku, 1980, Lack of correlation between induction of adjuvant arthritis and changes in metabolism and disposition of phenylbutazone in rats, Pharmacology, 20, 166, 10.1159/000137361 Jonkman, 1989, Effects of interferon on theophylline pharmacokinetics and metabolism, Br J Clin Pharmacol, 27, 795, 10.1111/j.1365-2125.1989.tb03442.x Kato, 1963, Enhanced phenobarbital induction of liver microsomal drug metabolizing enzymes in mice infected with murine hepatitis virus, Biochem Pharmacol, 12, 365, 10.1016/0006-2952(63)90063-7 Kempermann, 1994, Cytochrome P450 in rat astrocytes in vivo and in vitro: intracellular localization and induction by phenytoin, J Neurosci Res, 39, 576, 10.1002/jnr.490390509 Khatsenko, 1997, Nitric oxide differentially affects constitutive cytochrome P450 isoforms in rat liver, J Pharmacol Exp Ther, 280, 1463 Khatsenko, 1993, Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants, Proc Natl Acad Sci USA, 90, 11147, 10.1073/pnas.90.23.11147 Khatsenko, 1998, Role of nitric oxide in the inhibition of cytochrome P450 in the liver of mice infected with Chlamydia trachomatis, Biochem Pharmacol, 55, 1835, 10.1016/S0006-2952(98)00066-5 Kirby, 1996, Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis, Toxicol Pathol, 24, 458, 10.1177/019262339602400408 Kokwaro, 1993, Effect of malaria infection and endotoxin-induced fever on phenacetin O-deethylation by rat liver microsomes, Biochem Pharmacol, 45, 1235, 10.1016/0006-2952(93)90275-2 Kokwaro, 1993, Effect of malaria infection and endotoxin-induced fever on the metabolism of antipyrine and metronidazole in the rat, Biochem Pharmacol, 45, 1243, 10.1016/0006-2952(93)90276-3 Koren, 1985, Decrease in theophylline clearance causing toxicity during viral epidemics, J Asthma, 22, 75, 10.3109/02770908509079891 Korsova, 1995, The cytochrome P-450-dependent mono-oxygenase system of the liver and interleukin-1 production by the macrophages in adjuvant arthritis in rats under the influence of beta-carotene, Eksp Klin Farmakol, 58, 44 Kovalev, 1983, Inhibition of the cytochrome P-450-dependent monooxygenase system of the liver in rats with adjuvant arthritis, Patol Fiziol Eksp Terapiia, 29 Kraemer, 1982, Altered theophylline clearance during an influenza outbreak, Pediatrics, 69, 476, 10.1542/peds.69.4.476 Kurokohchi, 1992, Effects of interleukin 1 alpha on the activities and gene expressions of the cytochrome P450IID subfamily, Biochem Pharmacol, 44, 1669, 10.1016/0006-2952(92)90485-2 Lee, 1993, Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome, Clin Pharmacol Ther, 53, 529, 10.1038/clpt.1993.66 Leeson, 1976, Decrease in activity of the drug metabolizing enzymes of the rat following the administration of tilorone hydrochloride, Drug Metab Dispos, 4, 232 Lenton, 1996, Fasciola hepatica infection in sheep: changes in liver metabolism, Res Vet Sci, 61, 152, 10.1016/S0034-5288(96)90091-0 Li-Masters, 2001, Effects of bacterial lipopolysaccharide on phenobarbital-induced CYP2B expression in mice, Drug Metab Dispos, 29, 252 Liu, 2000, Endotoxin pretreatment protects against the hepatotoxicity of acetaminophen and carbon tetrachloride: role of cytochrome P450 suppression, Toxicology, 147, 167, 10.1016/S0300-483X(00)00193-1 Mannering, 1986, The pharmacology and toxicology of interferons. An overview, Annu Rev Pharmacol, 26, 455, 10.1146/annurev.pa.26.040186.002323 Mannering, 1988, Role of xanthine oxidase in the interferon mediated depression of cytochrome P450 system in mice, Cancer Res, 48, 2107 Matsuoka, 1989, Reduced levels of mutagen processing potential in the Schistosoma japonicum-infected mouse liver, Mutat Res, 227, 153, 10.1016/0165-7992(89)90039-0 Mayo, 2000, Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis, Br J Clin Pharmacol, 50, 605, 10.1046/j.1365-2125.2000.00314.x McCarthy, 1970, Effects of malarial infection on host microsomal drug-metabolizing enzymes, Biochem Pharmacol, 19, 1341, 10.1016/0006-2952(70)90049-3 Mitchell, 2001, Characterization of cyp4a induction in rat liver by inflammatory stimuli: dependence on sex, strain, and inflammation-evoked hypophagia, Drug Metab Dispos, 29, 17 Monshouwer, 1995, Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs, Drug Metab Dispos, 23, 44 Monshouwer, 1996, Differential effect of pentoxifylline on lipopolysaccharide-induced downregulation of cytochrome P450, Biochem Pharmacol, 52, 1195, 10.1016/0006-2952(96)00468-6 Monshouwer, 1996, A lipopolysaccharide-induced acute phase response in the pig is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism, J Vet Pharmacol Ther, 19, 382, 10.1111/j.1365-2885.1996.tb00068.x Monshouwer, 1996, Suppression of cytochrome P450- and UDP glucuronosyl transferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes, Toxicol Appl Pharmacol, 137, 237, 10.1006/taap.1996.0077 Monshouwer, 2000, Decrease in brain cytochrome P450 enzyme activities during infection and inflammation of the central nervous system, Neuroimmunomodulation, 8, 142, 10.1159/000054274 Montero, 1999, Induced expression of CYP2A5 in inflamed trematode-infested mouse liver, Mutagenesis, 14, 217, 10.1093/mutage/14.2.217 Moochhala, 1991, The effect of IFN-alpha-Con1 on hepatic cytochrome P-450 and protein synthesis and degradation in hepatic microsomes, Int J Immunopharmacol, 13, 903, 10.1016/0192-0561(91)90043-7 Moochhala, 1991, A role for xanthine oxidase in the loss of cytochrome P-450 evoked by interferon, Can J Physiol Pharmacol, 69, 944, 10.1139/y91-143 Moochhala, 1989, Induction and depression of cytochrome P-450-dependent mixed-function, Biochem Pharmacol, 38, 439, 10.1016/0006-2952(89)90383-3 Moore, 1983, Influence of various purified interferons on effects of drugs in mice, Res Commun Chem Pathol Pharmacol, 39, 113 Morales-Montor, 1999, Modified expression of steroid 5 alpha-reductase as well as aromatase, but not cholesterol side-chain cleavage enzyme, in the reproductive system of male mice during (Taenia crassiceps) cysticercosis, Parasitol Res, 85, 393, 10.1007/s004360050565 Morel, 1998, Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress — Critical contribution of nuclear factor 1, J Biol Chem, 273, 26969, 10.1074/jbc.273.41.26969 Morgan, 1989, Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin, Mol Pharmacol, 36, 699 Morgan, 1991, Suppression of P450IIC12 gene expression and elevation of actin messenger, Biochem Pharmacol, 42, 51, 10.1016/0006-2952(91)90680-4 Morgan, 1997, Regulation of cytochromes P450 during inflammation and infection, Drug Metab Rev, 29, 1129, 10.3109/03602539709002246 Morgan, 2001, Regulation of cytochrome P450 by inflammatory mediators: why and how?, Drug Metab Dispos, 29, 207 Morgan, 1990, Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in rat liver after administration of interferon inducers, Drug Metab Dispo, 18, 649 Morgan, 1994, Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver, Biochim Biophys Acta, 1219, 475, 10.1016/0167-4781(94)90074-4 Muntane, 1995, Effect of carrageenan-induced granuloma on hepatic cytochrome P-450 isozymes in rats, Inflammation, 19, 143, 10.1007/BF01534458 Muntane-Relat, 1995, Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture, Hepatology, 22, 1143, 10.1002/hep.1840220420 Nadai, 1998, Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats, J Pharm Pharmacol, 50, 871, 10.1111/j.2042-7158.1998.tb04002.x Nadin, 1995, Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor α, Gastroenterology, 109, 198, 10.1016/0016-5085(95)90285-6 Naik, 1995, Intensity of Schistosoma mansoni infection determines alterations in hepatic drug metabolism, J Egypt Soc Parasitol, 25, 157 Nicholson, 1999, Modulation of cytochrome P450 by inflammation in astrocytes, Brain Res, 827, 12, 10.1016/S0006-8993(99)01261-5 Nicholson, 2001, The role of cytokines in the depression of CYP1A activity using cultured astrocytes as an in vitro model of inflammation in the CNS, Drug Metab Dispos Nicholson, 2001, The role of cytokines in the lipopolysaccharide evoked depression of cytochrome P450 in the brain and liver, Biochem Pharmacol, 10.1016/S0006-2952(01)00859-0 Okuno, 1990, Depression of drug metabolizing activity in human liver by interferon-a, Eur J Clin Pharmacol, 39, 365, 10.1007/BF00315411 O'Neil, 2000, Genotype and phenotype of cytochrome P450 2D6 in human immunodeficiency virus-positive patients and patients with acquired immunodeficiency syndrome, Eur J Clin Pharmacol, 56, 231, 10.1007/s002280000116 Oyekan, 1995, The suppression by lipopolysaccharide of cytochrome P450-dependent renal vasodilation in the rat is mediated by nitric oxide, Eur J Pharmacol, 277, 123, 10.1016/0014-2999(95)00044-L Pan, 2000, Use of a novel real-time quantitative reverse transcription-polymerase chain reaction method to study the effects of cytokines on cytochrome P450 mRNA expression in mouse liver, Drug Metab Dispos, 28, 709 Park, 1995, The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity, Pharmacol Ther, 68, 385, 10.1016/0163-7258(95)02013-6 Parkinson, 1982, Effects of three recombinant human leukocyte interferons on drug metabolism in mice, Drug Metab Dispos, 10, 579 Pasanen, 1997, Hepatitis A impairs the function of human hepatic CYP2A6 in vivo, Toxicology, 123, 177, 10.1016/S0300-483X(97)00119-4 Peng, 2000, Promoter function and the role of cytokines in the transcriptional regulation of rabbit CYP2E1 and CYP2E2, Arch Biochem Biophys, 382, 129, 10.1006/abbi.2000.2001 Perrey, 1976, Elimination and distribution of phenylbutazone in rats during the course of adjuvant-induced arthritis, J Pharmacol Exp Ther, 197, 470 Perry, 1993, Macrophages and inflammation in the central nervous system, Trends Neurosci, 16, 268, 10.1016/0166-2236(93)90180-T Peterson, 1984, Depression of cytochrome P-450-dependent drug biotransformation in hepatocytes after the activation of the reticuloendothelial system by dextran sulfate, J Pharmacol Exp Ther, 229, 299 Peterson, 1986, Kupffer cell factor mediated depression of hepatic parenchymal cell cytochrome P-450, Biochem Pharmacol, 35, 1491, 10.1016/0006-2952(86)90114-0 Proulx, 1995, Inflammation-induced decrease in hepatic cytochrome P450 in conscious rabbits is accompanied by an increase in hepatic oxidative stress, Res Commun Mol Pathol Pharmacol, 87, 221 Rabovsky, 1986, Influenza virus-induced alterations of cytochrome P-450 enzyme activities following exposure of mice to coal and diesel particulates, Environ Res, 40, 136, 10.1016/S0013-9351(86)80089-5 Ragland, 1971, Interaction between duck hepatitis virus and DDT in ducks, Commun Chem Pathol Pharmacol, 2, 236 Renton, 1978, Altered theophylline kinetics, Lancet, ii, 160 Renton, 1979, The deleterious effect of Bordetella pertussis vaccine and poly(rI.rC) on the metabolism and disposition of phenytoin, J Pharmacol Exp Ther, 208, 267 Renton, 1994 Renton, 1990, Regulation of hepatic cytochrome P450 during infectious disease, Can J Physiol Pharmacol, 68, 777, 10.1139/y90-119 Renton, 1976, Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents, Biochem Biophys Res Commun, 73, 343, 10.1016/0006-291X(76)90713-0 Renton, 1976, Depression of the hepatic cytochrome P-450 mono-oxygenase system by administered tilorone (2,7-bis(2-(diethylamino)ethoxy)fluoren-9-one dihydrochloride), Drug Metab Dispos, 4, 223 Renton, 2000, Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain, J Pharmacol Exp Ther, 294, 524 Renton, 1978, Effects of polyribonoinosinic acid polyribocytidylic acid and a mouse interferon preparation on cytochrome P-450-dependent monooxygenase systems in cultures of primary mouse hepatocytes, Mol Pharmacol, 14, 672 Renton, 1979, Suppression of the inductive effects of phenobarbital and 3-methylcholanthrene on ascorbic acid synthesis and hepatic cytochrome P-450-linked monooxygenase systems by the interferon inducers, poly rI.rC and tilorone, Biochem Biophys Res Commun, 88, 1017, 10.1016/0006-291X(79)91510-9 Renton, 1999, Lipopolysaccharide evokes the modulation of brain cytochrome P4501A in the rat, Brain Res, 842, 139, 10.1016/S0006-8993(99)01773-4 Rothwell, 1996, Cytokines and their receptors in the central nervous system: physiology, pharmacology and pathology, Pharmacol Ther, 69, 85, 10.1016/0163-7258(95)02033-0 Sakai, 1992, Suppression of hepatic drug metabolism by the interferon inducer, J Pharmacol Exp Ther, 263, 381 Salehzada, 1993, 2′,5′-Oligoadenylate-dependent RNase L is a dimer of regulatory and catalytic subunits, J Biol Chem, 268, 7733, 10.1016/S0021-9258(18)53018-0 Samaras, 1953, Physiopathology of detoxification of pentobarbital sodium, Fed Am Soc Exp Biol, 12, 400 Sanne, 1995, Expression of cytochrome P450 side-chain cleavage enzyme and 3β-hydroxysteroid dehydrogenase in the rat central nervous system: a study by polymerase chain reaction and in situ hybridization, J Neurochem, 65, 528, 10.1046/j.1471-4159.1995.65020528.x Satarug, 1996, Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, Opisthorchiasis viverrini, Cancer Epidemiol Biomarkers Prev, 5, 795 Sewer, 1997, Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes, Biochem Pharmacol, 54, 729, 10.1016/S0006-2952(97)00226-8 Sewer, 1996, Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450, Drug Metab Dispos, 24, 401 Sewer, 1997, Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression, J Pharmacol Exp Ther, 280, 1445 Sewer, 1998, Down-regulation of cytochrome P450 mRNAs and proteins in mice lacking a functional NOS2 gene, Mol Pharmacol, 54, 273, 10.1124/mol.54.2.273 Shedlofsky, 1987, Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in mice, Life Sci, 40, 2331, 10.1016/0024-3205(87)90506-6 Shedlofsky, 1994, Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism, J Clin Invest, 94, 2209, 10.1172/JCI117582 Shedlofsky, 1997, Endotoxin depresses hepatic cytochrome P450-mediated drug metabolism in women, Br J Clin Pharmacol, 43, 627, 10.1046/j.1365-2125.1997.00603.x Shedlofsky, 2000, Depression of constitutive murine cytochromes P450 by staphylococcal enterotoxin B, Biochem Pharmacol, 59, 1295, 10.1016/S0006-2952(00)00250-1 Sheweita, 1998, Different levels of Schistosoma mansoni infection induce changes in drug-metabolizing enzymes, J Helminthol, 72, 71, 10.1017/S0022149X00001012 Shimamoto, 1998, Differential alterations in levels of hepatic microsomal cytochrome P450 isozymes following intracerebroventricular injection of bacterial lipopolysaccharide in rats, Arch Toxicol, 72, 492, 10.1007/s002040050533 Shimamoto, 1999, Mechanism of decrease in levels of hepatic P450 isozymes induced by intracerebral endotoxin: independence from sympathetic nervous and adrenocortical systems, Arch Toxicol, 73, 41, 10.1007/s002040050584 Siewert, 2000, Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent, Hepatology, 32, 49, 10.1053/jhep.2000.8532 Singh, 1981, Interferon-mediated depression of cytochrome P-450-dependent drug biotransformation, Mol Pharmacol, 20, 681 Singh, 1984, Inhibition of the synthesis of hepatic cytochrome P-450 by the interferon-inducing agent poly rI. rCi, Can J Physiol Pharmacol, 62, 379, 10.1139/y84-060 Singh, 1982, Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation, Biochem Biophys Res Commun, 106, 1256, 10.1016/0006-291X(82)91247-5 Skeith, 1997, Adverse drug reactions and debrisoquine/sparteine (P450IID6) polymorphism in patients with fibromyalgia, Clin Rheumatol, 16, 291, 10.1007/BF02238966 Somerville, 1995, A study of hepatic mitochondrial respiration and microsomal cytochrome P450 content in mice infected with the liver fluke Fasciola hepatica, Int J Parasitol, 25, 667, 10.1016/0020-7519(94)00197-V Sonawane, 1982, Effects of endotoxin upon rat hepatic microsomal drug metabolism in vivo and in vitro, Xenobiotica, 12, 303, 10.3109/00498258209052470 Sonne, 1985, Antipyrine clearance in pneumonia, Clin Pharmacol Ther, 37, 701, 10.1038/clpt.1985.117 Soyka, 1979, Role of mononuclear phagocytes in decreased hepatic drug metabolism following administration of Corynebacterium parvum, Int J Immunopharmacol, 1, 101, 10.1016/0192-0561(79)90012-2 Stanley, 1991, Differential effects of recombinant interferon alpha on constitutive and inducible cytochrome P450 isozymes in mouse liver, Biochem Pharmacol, 42, 311, 10.1016/0006-2952(91)90718-K Stern, 2000, Spatiotemporal induction patterns of cytokine and related immune signal molecule mRNAs in response to intrastriatal injection of lipopolysaccharide, J Neuroimmunol, 109, 245, 10.1016/S0165-5728(00)00318-0 Strobel, 1995, Expression of multiple forms of brain cytochrome P450, Toxicol Lett, 82-83, 639, 10.1016/0378-4274(95)03509-5 Taylor, 1985, Interferon reduces hepatic drug metabolism in vivo in mice, Drug Metab Dispos, 13, 459 Tindberg, 1996, Expression, catalytic activity, and inducibility of cytochrome P450 2E1 (CYP2E1) in the rat central nervous system, J Neurochem, 67, 2066, 10.1046/j.1471-4159.1996.67052066.x Tindberg, 1996, Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury, Mol Pharmacol, 50, 1065 Tinel, 1995, The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytes, Gastroenterology, 109, 1589, 10.1016/0016-5085(95)90648-7 Toda, 1994, Effect of adjuvant-induced arthritis on hepatic drug metabolism in rats, Xenobiotica, 24, 603, 10.3109/00498259409043263 Topfer, 1995, Importance of T-cell-dependent inflammatory reactions in the decline of microsomal cytochrome P450 concentration in the livers of rats infected with Fasciola hepatica, Int J Parasitol, 25, 1259, 10.1016/0020-7519(95)00052-4 Treluyer, 1996, Cytochrome P-450 expression in sudden infant death syndrome, Biochem Pharmacol, 52, 497, 10.1016/0006-2952(96)00253-5 Treluyer, 2000, Ontogenesis of CYP2C-dependent arachidonic acid metabolism in the human liver: relationship with sudden infant death syndrome, Pediatr Res, 47, 677, 10.1203/00006450-200005000-00020 Trenholme, 1976, Quinine disposition during malaria and during induced fever, Clin Pharmacol Ther, 19, 459, 10.1002/cpt1976194459 Uhl, 1999, Effects of Plasmodium berghei infection on cytochromes P-450 2E1 and 3A2, Eur J Drug Metab Pharmacokinet, 24, 169, 10.1007/BF03190365 Volk, 1995, Localization and characterization of cytochrome P450 in the brain. In vivo and in vitro investigations on phenytoin- and phenobarbital-inducible isoforms, Toxicol Lett, 82-83, 655, 10.1016/0378-4274(95)03511-7 Walker, 1982, Theophylline toxicity and viral infection, Pediatrics, 70, 508, 10.1542/peds.70.3.508 Wilckens, 1995, Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction, Trends Pharmacol Sci, 16, 193, 10.1016/S0165-6147(00)89021-5 Williams, 1986, Inhibition of antipyrine metabolism by interferon, Br J Clin Pharmacol, 22, 610, 10.1111/j.1365-2125.1986.tb02943.x Williams, 1987, Inhibition of theophylline metabolism by interferon, Lancet, ii, 939, 10.1016/S0140-6736(87)91422-X Wink, 1993, Inhibition of cytochromes P450 by nitric oxide and a nitric oxide releasing agent, Arch Biochem Biophys, 300, 115, 10.1006/abbi.1993.1016 Woiciechowsky, 1998, Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced brain injury, Nat Med, 4, 808, 10.1038/nm0798-808 Woiciechowsky, 1999, Brain IL-1beta induces local inflammation but systemic anti-inflammatory response through stimulation of both hypothalamic-pituitary-adrenal axis and sympathetic nervous system, Brain Res, 816, 563, 10.1016/S0006-8993(98)01238-4 Woo, 1980, Acute intoxication with theophylline while on chronic therapy, Vet Hum Toxicol, 22, 48 Wright, 1990, Transcriptional and post-transcriptional supression of P450IIC11 and P450IIC12 by inflammation, FEBS Lett, 271, 59, 10.1016/0014-5793(90)80371-O Wright, 1991, Regulation of cytochrome P450IIC12 expression by interleukin-1 alpha, interleukin-6, and dexamethasone, Mol Pharmacol, 39, 468